The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Rauscher Steven M since 2007.
The trader's CIK number is 1166683.
At the time of the last reporting, Rauscher Steven M was the CEO and President of Acorda Therapeutics Inc. (stock ticker symbol ACOR).
Also see all insider trading activities at Acorda Therapeutics Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2007 | OSCI | 10,000 | $27,095 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2018 | ACOR | 0 | $0 | 10,000 | $245,850 | 10,000 | $201,600 |
2017 | ACOR | 0 | $0 | 10,000 | $215,700 | 10,000 | $182,100 |
2016 | ACOR | 0 | $0 | 1,086 | $30,224 | 1,086 | $20,253 |
2015 | ACOR | 0 | $0 | 2,698 | $94,179 | 2,698 | $21,961 |
2010 | ACOR | 0 | $0 | 30,000 | $1,086,300 | 30,000 | $244,200 |
1. Oscient Pharmaceuticals Corp (OSCI)
2. Acorda Therapeutics Inc (ACOR)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2007-09-12 | OSCI | Buy | 5,532 | 2.69 | 14,853 |
2007-09-13 | OSCI | Buy | 1,796 | 2.73 | 4,894 |
2007-09-14 | OSCI | Buy | 2,672 | 2.75 | 7,348 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-05-15 | ACOR | Sale | 10,000 | 24.59 | 245,850 |
2018-05-15 | ACOR | Option Ex | 10,000 | 20.16 | 201,600 |
2017-08-01 | ACOR | Sale | 10,000 | 21.57 | 215,700 |
2017-08-01 | ACOR | Option Ex | 10,000 | 18.21 | 182,100 |
2016-06-08 | ACOR | Option Ex | 1,086 | 18.65 | 20,253 |
2016-06-08 | ACOR | Sale | 1,086 | 27.83 | 30,224 |
2015-03-04 | ACOR | Option Ex | 2,698 | 8.14 | 21,961 |
2015-03-04 | ACOR | Sale | 2,698 | 34.91 | 94,179 |
2010-08-05 | ACOR | Option Ex | 30,000 | 8.14 | 244,200 |
2010-08-05 | ACOR | Sale | 30,000 | 36.21 | 1,086,300 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rauscher Steven M (CEO and President of Acorda Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.